Table 4. Systemic diseases/conditions reported linked to distinct oral microbiome.
| Alzheimer’s Disorder |
| Barrett’s Esophagus |
| Cancer |
| Cardiovascular Disease |
| Celiac Disease |
| Cervical myelodysplasia |
| Chronic obstructive pulmonary disease |
| Congestive Heart Failure |
| Dementia |
| Depression |
| Emphysema |
| Epilepsy |
| Gastroesophageal Reflux Disease |
| Glaucoma |
| Gout |
| Hypercholesterolemia |
| Hyperlipidemia |
| Hypertension |
| Idiopathic Bowel Disease |
| Kidney Disease |
| Multiple Sclerosis |
| Muscle Weakness |
| Neuropsychiatric Disorder |
| Obesity |
| Osteoarthritis |
| Peripheral Vascular Disease |
| Polycystic Kidney Disease |
| Post Traumatic Stress Disorder |
| Psoriasis |
| Pulmonary Hypertension |
| Rheumatoid Arthritis |
| Seizures |
| Sjogren’s Syndrome |
| Stroke |
| Systemic Lupus Erythematosus |
| T1DM |
| T2DM |
Notes.
1
List of condition and disease (Table S3) is limited to those known to be associated with oral microbial taxa differences.
2
Negative coefficient indicates taxa that decrease with high number of disease/conditions.
3
Taxa with differential level of significance at False Discovery Rate of q < 0.1.